Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)

The summary for the Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed): The purpose of this notice of funding opportunity (NOFO) is to invite applications from research institutions in low- and middle-income countries (LMICs) to provide senior administrators from these institutions with advanced training in the management of NIH grants. The goal is to improve oversight of NIAID grant awards and compliance with NIH funding policies and Federal research funding requirements for NIAID-supported foreign institutions in LMICs.
Federal Grant Title: Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-23-300
Type of Funding: Grant
CFDA Numbers: 93.855
CFDA Descriptions: Information not provided
Current Application Deadline: March 13th, 2026
Original Application Deadline: March 13th, 2026
Posted Date: September 11th, 2023
Creation Date: September 11th, 2023
Archive Date: April 18th, 2026
Total Program Funding:
Maximum Federal Grant Award: $100,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: September 12th, 2023
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations).
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/pa-files/PAR-23-300.html
Grant Announcement Contact
NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Anti...
Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
Center for HIV/AIDS Vaccine Immunology (CHAVI)
Genomics of Transplantation Cooperative Research Program
Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/U...
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/U...
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com